Standalone middle meningeal artery embolization versus middle meningeal artery embolization with concurrent surgical evacuation for chronic subdural hematomas: a multicenter propensity score matched analysis of clinical and radiographic outcomes
- 6 November 2023
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (12) , 1313-1319
Abstract
Background Middle meningeal artery embolization (MMAE) has emerged as a promising therapy for chronic subdural hematomas (cSDHs). The efficacy of standalone MMAE compared with MMAE with concurrent surgery is largely unknown. Methods cSDH patients who underwent successful MMAE from 14 high volume centers with at least 30 days of follow-up were included. Clinical and radiographic variables were recorded and used to perform propensity score matching (PSM) of patients treated with standalone MMAE or MMAE with concurrent surgery. Multivariable logistic regression models were used for additional covariate adjustments. The primary outcome was recurrence requiring surgical rescue, and the secondary outcome was radiographic failure defined as Results 722 MMAE procedures in 588 cSDH patients were identified. After PSM, 230 MMAE procedures remained (115 in each group). Median age was 73 years, 22.6% of patients were receiving anticoagulation medication, and 47.9% had no preoperative functional disability. Median midline shift was 4 mm and cSDH thickness was 16 mm, representing modestly sized cSDHs. Standalone MMAE and MMAE with surgery resulted in similar rates of surgical rescue (7.8% vs 13.0%, respectively, P=0.28; adjusted OR (aOR 0.73 (95% CI 0.20 to 2.40), P=0.60) and radiographic failure (15.5% vs 13.7%, respectively, P=0.84; aOR 1.08 (95% CI 0.37 to 2.19), P=0.88) with a median follow-up duration of 105 days. These results were similar across subgroup analyses and follow-up durations. Conclusions Standalone MMAE led to similar and durable clinical and radiographic outcomes as MMAE combined with surgery in select patients with moderately sized cSDHs and mild clinical disease.Keywords
This publication has 22 references indexed in Scilit:
- Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive EmbolizationsNeurosurgery, 2020
- To drill or not to drill, that is the question: nonsurgical treatment of chronic subdural hematoma in the elderly. A systematic reviewNeurosurgical Focus, 2020
- Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematomaJournal of NeuroInterventional Surgery, 2020
- The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish populationJournal of Neurosurgery, 2020
- Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorptionJournal of NeuroInterventional Surgery, 2019
- Middle Meningeal Artery Embolization for Chronic Subdural HematomaRadiology, 2018
- Embolization Therapy for Refractory Hemorrhage in Patients with Chronic Subdural HematomasWorld Neurosurgery, 2017
- Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populationsJournal of Neurosurgery, 2015
- Multiple significance tests: the Bonferroni methodBMJ, 1995
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988